A detailed history of Ropes Wealth Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ropes Wealth Advisors LLC holds 34,266 shares of ABBV stock, worth $6.67 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
34,266
Previous 38,457 10.9%
Holding current value
$6.67 Million
Previous $5.18 Million 1.43%
% of portfolio
1.0%
Previous 0.87%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

SELL
$133.59 - $154.65 $559,875 - $648,138
-4,191 Reduced 10.9%
34,266 $5.11 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $95,672 - $119,057
722 Added 1.91%
38,457 $5.18 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $4,482 - $5,162
31 Added 0.08%
37,735 $6.01 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $145,917 - $174,992
1,055 Added 2.88%
37,704 $6.1 Million
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $492,416 - $564,769
3,669 Added 11.12%
36,649 $4.92 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $16,239 - $20,645
-118 Reduced 0.36%
32,980 $5.05 Million
Q1 2022

May 04, 2022

SELL
$131.98 - $163.75 $117,198 - $145,410
-888 Reduced 2.61%
33,098 $5.37 Million
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $1.08 Million - $1.37 Million
-10,057 Reduced 22.83%
33,986 $4.6 Million
Q3 2021

Nov 05, 2021

BUY
$106.4 - $120.78 $31,600 - $35,871
297 Added 0.68%
44,043 $4.75 Million
Q2 2021

Aug 04, 2021

SELL
$105.21 - $117.21 $49,974 - $55,674
-475 Reduced 1.07%
43,746 $4.93 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $439,173 - $483,477
4,293 Added 10.75%
44,221 $5.08 Million
Q4 2020

Feb 05, 2021

SELL
$80.49 - $108.67 $159,772 - $215,709
-1,985 Reduced 4.74%
39,928 $4.28 Million
Q3 2020

Oct 16, 2020

SELL
$85.91 - $100.83 $202,060 - $237,152
-2,352 Reduced 5.31%
41,913 $3.67 Million
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $131,112 - $175,447
1,787 Added 4.21%
44,265 $4.35 Million
Q1 2020

Apr 24, 2020

BUY
$64.5 - $97.79 $62,823 - $95,247
974 Added 2.35%
42,478 $3.24 Million
Q4 2019

Feb 05, 2020

SELL
$72.13 - $90.25 $379,764 - $475,166
-5,265 Reduced 11.26%
41,504 $3.68 Million
Q3 2019

Nov 05, 2019

BUY
$62.98 - $75.72 $287,566 - $345,737
4,566 Added 10.82%
46,769 $3.54 Million
Q2 2019

Jul 31, 2019

SELL
$65.7 - $83.98 $50,260 - $64,244
-765 Reduced 1.78%
42,203 $3.07 Million
Q1 2019

Apr 15, 2019

SELL
$77.14 - $90.79 $191,307 - $225,159
-2,480 Reduced 5.46%
42,968 $3.46 Million
Q4 2018

Feb 08, 2019

BUY
$77.85 - $96.01 $389 - $480
5 Added 0.01%
45,448 $4.19 Million
Q3 2018

Oct 30, 2018

BUY
$88.91 - $98.84 $496,117 - $551,527
5,580 Added 14.0%
45,443 $4.3 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $8,798 - $10,410
98 Added 0.25%
39,863 $3.69 Million
Q1 2018

Apr 30, 2018

BUY
$92.01 - $123.21 $368 - $492
4 Added 0.01%
39,765 $3.76 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $313,012 - $343,243
3,495 Added 9.64%
39,761 $3.85 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $2.53 Million - $3.24 Million
36,266
36,266 $3.22 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ropes Wealth Advisors LLC Portfolio

Follow Ropes Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ropes Wealth Advisors LLC with notifications on news.